| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736004 | Allergologia et Immunopathologia | 2017 | 6 Pages |
Abstract
Icariin is a promising therapeutic strategy for asthma, and PGD2 might be a new target for asthma therapy in OVA-induced and RSV-infected asthma model.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J. Qiao, S. Sun, L. Yuan, J. Wang,